Insulin makers grilled on price surge, as diabetics struggle to afford life-saving meds
Pressure from Congress appears to be spurring the pharmaceutical industry to lower prescription drug prices for some patients. One of the main producers of insulin, Sanofi, said it will cap the cost of the life-saving drug for diabetics. Some could save thousands of dollars a year. Anna Werner reports.